Letters
(Not) warts and all
All data on both vaccines must be considered
BMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a2554 (Published 19 November 2008) Cite this as: BMJ 2008;337:a2554
- Pim Kon, medical director1
- 1GlaxoSmithKline UK, Uxbridge UB11 1BT
- pim.7.kon{at}gsk.com
The government chose the human papillomavirus (HPV) vaccine of GlaxoSmithKline (GSK), Cervarix, after considering protection against cancer causing HPV 16 and 18, HPV 6 and 11 (which cause genital warts), and HPV strains not included in the vaccine formulation; price; and supply.1
Its decision was based on a comprehensive review of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.